Abstract:Objective To screen potential serum HCC associated proteins with low molecular weight and low abundance for better understanding the pathological mechanism of HCC and discovering new biomarkers.Methods All serum samples were collected from 81 HBV-related HCC patients,43 chronic hepatitis B patients and 36 cirrhosis patients.Serum protein fingerprint profiles were first generated by selected WCX2 protein chip integrating with SELDI-TOF-MS,and then normalized and aligned by Ciphergen SELDI Software 3.1.1 with Biomarker Wizard.Comparative analysis of the intensity of corresponding protein fingerprint peaks in normalized protein spectra was performed.Some protein peaks with significant difference among HCC,cirrhosis and chronic hepatitis B groups were found.The reproducibility of the SELDI system was assessed before serum protein fingerprint profiles analysis.Results The intra-and inter-assay CV for intensity and m/z in this SELDI system were 17.46% and 0.024%,and 17.74% and 0.024% respectively.Total 128 protein fingerprint peaks between 2 000 to 30 000 Da were identified under the condition of signal to noise＞5 and minimum threshold for cluster＞20%.Eighty-seven proteins were found to significantly expressed between HCC and cirrhosis groups(P＜0.05).Of the above differential proteins,forty-five proteins had changes greater than two fold,including 15 up-regulated proteins and 30 downregulated proteins in HCC sera.Between HCC and chronic hepatitis B groups,nine of fifty-two differential proteins(P＜0.05) had intensities of more than two folds,including 2 up-regulated proteins and 7 downregulated proteins in HCC sera.Between cirrhosis and chronic hepatitis B groups,twenty-eight of seventynine significantly differential proteins(P＜0.05) changed greater than two folds in intensity,including 17 up-regulated proteins in cirrhosis seru and 11 down-regulated proteins in chronic hepatitis B sera.Analysis of above leading differential proteins among three diseases using subtraction difference mode,the 5 common down-regulated proteins 2 870,3 941,2 688,3 165 and 5 483 m/z in HCC sera and 2 common up-regulated proteins 3 588 and 2 017 m/z in cirrhosis and HCC sera were screened.But no statistic difference in the level of protein 2 017m/z was found between HCC group and normal group inour previous study.Conclusion Because the interference of unspecific proteins from hepatitis B and cirrhosis could be eliminated partly in HCC sera through subtraction difference analysis,these 6 common differential proteins (2 870,3 941,2 688,3 165,5 483,3 588 m/z)have obvious advantages of increased specificity for evaluating the pathological state of HCC and might become promising candidate biomarkers in the diagnosis of HCC.\r\n\r\nKey words: \r\nLiver neoplasms; Carcinoma,hepatocellular; Spectrometry,mass,matrix-assisted laser desorption ionization; Protein array analysis; Biological marker

Analysis of Low Abundance Diferential Proteins in Plasma from Hepatocellular Carcinomas Patients by Multi-dimensional Chromatography Tandem Mass Spectrometry

Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma

Quantitative Proteomic Analysis for High-Throughput Screening of Differential Glycoproteins in Hepatocellular Carcinoma Serum

Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.

Screening Serum Hepatocellular Carcinoma-Associated Proteins by SELDI-based Protein Spectrum Analysis

HCC serum associated proteins screened by SELDI-TOF-MS analysis

Quantitative proteomics identifies a plasma multi-protein model for detection of hepatocellular carcinoma

Development of Glycoprotein Capture-Based Label-Free Method for the High-throughput Screening of Differential Glycoproteins in Hepatocellular Carcinoma

Comparative Plasma Membrane-Associated Proteomics of Immortalized Human Hepatocytes

Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS.

Search for Potential Serum Biomarkers in Hepatocellular Carcinoma Using iTRAQ-Coupled LC-MS/MS

Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues

Plasma Lipidomic Analysis to Identify Novel Biomarkers for Hepatocellular Carcinoma

Proteome Analysis of Hepatocellular Carcinoma by Two-dimensional Difference Gel Electrophoresis

Preliminary Study on Differential Proteomic Analysis of Hepatic Tissues in HBV Related Hepatocellular Carcinoma

Screening Differential Expression of Serum Proteins in AFP-negative HBV-related Hepatocellular Carcinoma Using Itraq -MALDI-MS/MS.

Proteomic Analysis of Hepatitis B Virus-Associated Hepatocellular Carcinoma: Identification of Potential Tumor Markers

Tandem Mass Tag-Based Proteomic Analysis of Potential Biomarkers for Hepatocellular Carcinoma Differentiation

Proteomic and Phosphor-Proteomic Signatures of Clinical Hepatitis B Virus-Associated Hepatocellular Carcinoma

Proteomic Profiling of N-linked Glycoproteins Involved in Hepatocellular Carcinoma by Two-dimensional Electrophoresis and Mass Spectrometry

Differential Proteomics Identification of HSP90 As Potential Serum Biomarker in Hepatocellular Carcinoma by Two-dimensional Electrophoresis and Mass Spectrometry